Abstract
Precision gene editing enables massively parallel identification of cancer-promoting genes.
MeSH terms
-
Animals
-
Antineoplastic Agents* / pharmacology
-
Antineoplastic Agents* / therapeutic use
-
CRISPR-Cas Systems*
-
Drug Discovery*
-
Gene Editing* / methods
-
Humans
-
Neoplasms* / drug therapy
-
Neoplasms* / genetics